Investing.com - European stock markets were mixed on Monday, as shares in pharmaceutical firms fell after new criticism was leveled at GlaxoSmithKline over its diabetes drug Avandia.
During European morning trade, Germany's DAX was down 0.02%; the EURO STOXX 50 slipped 0.11%; and Spain's IBEX 35 was down 0.79%.
But France's CAC 40 was up 0.02% and Britain's FTSE 100 rose 0.15%.
British pharmaceutical giant GlaxoSmithKline fell 2.1% in the wake of a call by two U.S. drug safety reviewers for Avandia to be pulled from the market. Shares in the firm's peers Roche, AstraZeneca and Sanofi-Aventis also slipped.
Also Monday, fears over Greece apparently abated somewhat following a report on Saturday that Germany's finance ministry had readied plans for euro zone nations to help the debt-ridden nation.
The outlook for U.S. markets, meanwhile, was quite positive: Dow Jones Industrial Average futures indicated a rise of 0.1%, S&P 500 futures pointed to an increase of 0.02% and Nasdaq 100 futures indicated a rise of 0.11%.